BioSpace News Archive

Resverlogix Corp. announced that Ken Lebioda is stepping down as Senior Vice President, Business and Corporate Development, effective immediately.

Advaxis, Inc. and Biosight Ltd., a privately held pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, announced that the companies have entered into a definitive merger agreement pursuant to which the shareholders of Biosight will become the majority holders of the combined company immediately following completion of the transaction.

Seegene announced on July 1 that it has signed a partnership with Bio-Rad, laboratories, Inc. for the clinical development and commercialization of infectious disease molecular diagnostic products.

Clover Biopharmaceuticals announced the completion of targeted enrollment of adult and elderly participants in SPECTRA, a global pivotal Phase 2/3 clinical trial evaluating the efficacy, safety and immunogenicity of SCB-2019, Clover’s COVID-19 vaccine candidate.

MiNA Therapeutics Limited, the pioneer in small activating RNA therapeutics, announces that Eli Lilly and Company has entered into a definitive agreement under which it will make a direct equity investment in MiNA.

The global demand for medical device CRO is slated to rise at a sturdy pace in the times of follow. The presence of a seamless industry for managing medical technologies and fresh developments in healthcare has emerged as an important dynamic of market growth.

Disposable blood bags’ is a term primarily associated with storage, collection, transportation as well as transfusion of blood along with its components viz. RBCs, WBCs, and platelets.

A brain perfusion scan is a type of brain test that provides information about brain function by demonstrating the amount of blood taken up by the brain cells and measure perfusion in the brain.

The Fact MR survey offers comprehensive canine separation anxiety treatment market analysis, covering factors affecting sales across key segments including drug type and distribution channel.

The cardiac ablation technologies market survey offers insights into chief growth drivers and restrains impacting the overall growth trajectory.